Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion

Journal of Neurochemistry

Volumn 67, Issue 4, 1996, Pages 1653-1660

  Grasbon Frodl, Eva M ^a   Andersson, Anders ^b   Brundin, Patrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell culture; HPLC; L Buthionine sulfoximine; Lazaroids; Neural transplantation; Oxidative stress; Parkinson's disease

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; GLUTATHIONE; LAZAROID; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CATECHOLAMINE DEPLETION; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CELL TRANSPLANTATION; CULTURE MEDIUM; EMBRYO DEVELOPMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MESENCEPHALON; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029817315     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67041653.x     Document Type: Article

References (54)

1. Akerboom T. P. M. and Sies H. (1989) Transport of glutathione, glutathione disulfide, and glutathione conjugates across the hepatocyte plasma membrane. Methods Enzymol. 173, 523-534.
2. Althaus J. S., Oien T. T., Fici G. J., Scherch H. M., Strautmann A. F., Sethy V. H., and Von Voigtlander P. F. (1993) Peroxynitrite (POX) scavengers: possible neuroprotectants against nitric oxide (NO)-dependent toxicity. Soc. Neurosci. Abstr. 19, 1482.
3. Andersson A., Isaksson A., Brattström L., and Hultberg B. (1993) Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin. Chem. 39, 1590-1597.
4. Brundin P., Strecker R. E., Widner H., Clarke D. J., Nilsson O. G., Åstedt B., Lindvall O., and Björklund A. (1988) Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 70, 192-208.
5. Colton C. A., Pagan F., Snell J., Colton J. S., Cummins A., and Gilbert D. L. (1995) Protection from oxidation enhances the survival of cultured mesencephalic neurons. Exp. Neurol. 132, 54-61.
6. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
7. Dexter D. T., Jenner P., Schapira A. H. V., and Marsden C. D. (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann. Neurol. 32 (Suppl.), S94-S100.
8. Dexter D. T., Holley A. E., Flitter W. D., Slator T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden C. D. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9, 92-97.
9. Farlie P. G., Dringen R., Rees S. M., Kannourakis G., and Bernard O. (1995) Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. USA 92, 4397-4401.
10. Frodl E. M., Duan W. M., Sauer H., Kupsch A., and Brundin P. (1994a) Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 647, 286-298.
11. Frodl E. M., Nakao N., and Brundin P. (1994b) Lazaroids improve the survival of cultured rat embryonic mesencephalic neurons. Neuroreport 5, 2393-2396.
12. Grasbon-Frodl E. M. and Brundin P. (1996) Mesencephalic neuron death induced by congeners of nitrogen monoxide is prevented by the lazaroid U-83836E. Exp. Brain Res. (in press).
13. Grasbon-Frodl E. M., Nakao N., and Brundin P. (1996) Lazaroids improve the survival of embryonic mesencephalic donor tissue stored at 4°C and subsequently used for cultures or intracerebral transplantation. Brain Res. Bull. 39, 341-347.
14. Griffith O. (1982) Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257, 13704-13712.
15. Hall E. D., McCall J. M., and Means E. D. (1994) Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmacol. 28, 221-268.
16. Han S.-K., Mytilineou C., and Cohen G. (1996) L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66, 501-510.
17. Hornykiewicz O. and Kish S. J. (1987) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 19-34.
18. Jain A., Mårtensson J., Stole E., Auld P. A. M., and Meister A. (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. USA 88, 1913-1917.
19. Janetzky B., Hauck S., Youdim M. B. H., Riederer P., Jellinger K., Pantucek F., Zöchling R., Boissl K. W., and Reichmann H. (1994) Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 169, 126-128.
20. Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Örd T., and Bredesen D. E. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277.
21. Kondo T., Dale G. L., and Beutler E. (1995) Thiol transport from human red blood cells. Methods Enzymol. 252, 72-82.
22. Kordower J. H., Freeman T. B., Snow B. J., Vingerhoets F. J. G., Muffson E. J., Sanberg P. R., Hauser R. A., Smith D. A., Nauert G. M., Perl D. P., and Olanow C. W. (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118-1124.
23. Lindvall O. (1994) Neural transplantation in Parkinson's disease, in Functional Neural Transplantation (Björklund A. and Dunnett S. B., eds), pp. 103-137. Raven Press, New York.
24. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. Makar T. K., Nedergaard M., Preuss A., Gelbard A. S., Perumal A. S., and Cooper A. J. L. (1994) Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62, 45-53.
26. Martinou J. C., Dubois-Dauphin M., Staple J. K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., and Huarte J. (1994) Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13, 1017-1030.
27. McCay P. B., Gibson D. D., and Hornbrook K. R. (1981) Glutathione-dependent inhibition of lipid peroxidation by a soluble, heat-labile factor not glutathione peroxidase. Fed. Proc. 40, 199-205.
28. Meister A. (1994) Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269, 9397-9400.
29. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., and Kagawa Y. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
30. Nakao N., Frodl E. M., Duan W. M., Widner H., and Brundin P. (1994) Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 91, 12408-12412.
31. Nakao N., Frodl E. M., Widner H., Carlson E., Eggerding F. A., Epstein C. J., and Brundin P. (1995) Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med. 1, 226-231.
32. Olanow C. W. (1993) A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444.
33. Olanow C. W. and Cohen G. (1992) The pathogenesis of Parkinson's disease, in The Scientific Basis for the Treatment of Parkinson's Disease (Olanow C. W. and Liebermann A. N., eds), pp. 59-76. Parthenon Publishing Group, Park Ridge, New Jersey.
34. Olanow C. W., Kordower J. H., and Freeman T. B. (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102-109.
35. Perry T. L., Godin D. V., and Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310.
36. Pileblad E., Magnusson T., and Fomstedt B. (1989) Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striaturn. J. Neurochem. 52, 978-980.
37. Pileblad E., Eriksson P. S., and Hansson E. (1991) The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem. J. Neural Transm. 86, 43-49.
38. Raps S. P., Lai J. C. K., Hertz L., and Cooper A. J. L. (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res. 493, 398-401.
39. Reed D. J. (1990) Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30, 603-631.
40. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G. P., Jellinger K., and Youdim M. B. H. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
41. Sagara J., Miura K., and Bannai S. (1993) Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61, 1672-1676.
42. Saggu H., Cocksey J., Dexter D., Wells F. R., Lees A., Jenner P., and Marsden C. D. (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem. 53, 692-697.
43. Sanchez-Ramos J. R., Song S., Mash D. C., and Weiner W. J. (1992) 21-Aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicity. J. Neurochem. 58, 328-334.
44. Sauer H. and Brundin P. (1991) Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci. 2, 123-135.
45. Schapira A. H. V., Cooper J. M., Dexter D., Jenner P., Clark J. B., and Marsden C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
46. Schapira A. H. V., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B., and Marsden C. D. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
47. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden C. D. (1994a) Alterations in glucathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355.
48. Sian J., Dexter D. T., Lees A. J., Daniel S., Jenner P., and Marsden C. D. (1994b) Glutathione-related enzymes in Parkinson's disease. Ann. Neurol. 36, 356-361.
49. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G. P., Hebenstreit G., and Youdim M. B. H. (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 74, 199-205.
50. Sofic E., Paulus W., Jellinger K., Riederer P., and Youdim M. B. H. (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56, 978-982.
51. Spina M. B. and Cohen G. (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad. Sci. USA 86, 1398-1400.
52. Spina M. B., Squinto S. P., Miller J., Lindsay R. M., and Hyman C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenyl-pyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99-106.
53. Wesemann W., Solbach M., Nafe R., Grote C., Sontag K. H., Riederer P., Jellinger K., Mennel H. D., and Clement H. W. (1995) Effect of lazaroid U-74389G on iron-induced reduction of striatal metabolism. J. Neural Transm. Suppl. 46, S175-S182.
54. Younes M. and Siegers C. P. (1980) Lipid peroxidation as a consequence of glutathione depletion in rat and mouse liver. Res. Commun. Chem. Pathol. Pharmacol 27, 119-128.